Orchestra Bio

IPO

Manage the business of science

Public · San Francisco, United States · $70.0M raised

Employees
11–50
Business Model
B2B
Total Funding
$70.0M
Last Round
$70.0M Corporate RoundJul 2025
Rounds
1
Type
Public

About

Orchestra is an intelligent management platform for R&D organizations, helping biotech and pharmaceutical companies manage the business of science. The platform provides tools for R&D planning, program management, portfolio prioritization, and operational oversight, enabling teams to align scientific programs with strategic goals and track progress across complex multi-stage pipelines.

Summary

Orchestra Bio is a Healthcare company based in San Francisco, United States. It has raised $70.0M in total across 1 round, most recently a $70.0M Corporate Round round in Jul 2025. Investors include Medtronic and Ligand Pharmaceuticals.

Tech & App Stack

11 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOAug 2025
$56.2M

Sign up to see all 2 rounds

Corporate Round through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Orchestra Bio on Indexed.vc
<a href="https://indexed.vc/companies/orchestra-bio"><img src="https://indexed.vc/api/badge/company/orchestra-bio" alt="Orchestra Bio on Indexed.vc" width="260" height="76" /></a>